AllianceBernstein’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-64,310
| Closed | -$102K | – | 3353 |
|
|
2024
Q1 | $102K | Hold |
64,310
| – | – | ﹤0.01% | 3027 |
|
|
2023
Q4 | $55.2K | Sell |
64,310
-4,300
| -6% | -$3.69K | ﹤0.01% | 3123 |
|
|
2023
Q3 | $73.4K | Sell |
68,610
-4,680
| -6% | -$5.01K | ﹤0.01% | 3095 |
|
|
2023
Q2 | $190K | Buy |
73,290
+10,490
| +17% | +$27.2K | ﹤0.01% | 2994 |
|
|
2023
Q1 | $256K | Buy |
62,800
+3,300
| +6% | +$13.5K | ﹤0.01% | 2831 |
|
|
2022
Q4 | $299K | Buy |
59,500
+20,900
| +54% | +$105K | ﹤0.01% | 2875 |
|
|
2022
Q3 | $505K | Hold |
38,600
| – | – | ﹤0.01% | 2639 |
|
|
2022
Q2 | $495K | Buy |
38,600
+10,900
| +39% | +$140K | ﹤0.01% | 2684 |
|
|
2022
Q1 | $422K | Sell |
27,700
-1,900
| -6% | -$28.9K | ﹤0.01% | 2737 |
|
|
2021
Q4 | $524K | Sell |
29,600
-41,976
| -59% | -$743K | ﹤0.01% | 2712 |
|
|
2021
Q3 | $1.51M | Buy |
71,576
+35,276
| +97% | +$742K | ﹤0.01% | 2307 |
|
|
2021
Q2 | $716K | Buy |
36,300
+11,600
| +47% | +$229K | ﹤0.01% | 2653 |
|
|
2021
Q1 | $718K | Sell |
24,700
-5,100
| -17% | -$148K | ﹤0.01% | 2519 |
|
|
2020
Q4 | $903K | Sell |
29,800
-1,400
| -4% | -$42.4K | ﹤0.01% | 2329 |
|
|
2020
Q3 | $496K | Sell |
31,200
-1,300
| -4% | -$20.7K | ﹤0.01% | 2530 |
|
|
2020
Q2 | $642K | Buy |
32,500
+5,800
| +22% | +$115K | ﹤0.01% | 2438 |
|
|
2020
Q1 | $329K | Buy |
26,700
+12,000
| +82% | +$148K | ﹤0.01% | 2567 |
|
|
2019
Q4 | $272K | Buy |
14,700
+1,600
| +12% | +$29.6K | ﹤0.01% | 2805 |
|
|
2019
Q3 | $181K | Buy |
+13,100
| New | +$181K | ﹤0.01% | 2959 |
|